HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rossella Elisei Selected Research

Cachexia

3/2022Nutrition in Advanced Thyroid Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rossella Elisei Research Topics

Disease

67Thyroid Neoplasms (Thyroid Cancer)
10/2022 - 09/2002
48Neoplasms (Cancer)
10/2022 - 09/2002
21medullary Thyroid cancer
01/2022 - 01/2004
16Papillary Thyroid Cancer
02/2021 - 12/2002
9Neoplasm Metastasis (Metastasis)
01/2022 - 09/2002
8Anaplastic Thyroid Carcinoma
02/2021 - 02/2003
7Thyroid Nodule (Nodule, Thyroid)
01/2019 - 12/2002
7Disease Progression
01/2016 - 08/2009
6Fatigue
01/2021 - 10/2013
6Hypertension (High Blood Pressure)
09/2016 - 01/2012
5Lymphatic Metastasis
01/2022 - 10/2007
5Hypothyroidism
01/2022 - 09/2002
5Nausea
09/2016 - 01/2012
5Diarrhea
01/2016 - 01/2012
4Adenoma (Adenomas)
11/2011 - 05/2003
3Thyrotoxicosis
01/2022 - 12/2005
3Thyroid Diseases (Thyroid Disease)
12/2016 - 01/2004
3Exanthema (Rash)
09/2016 - 01/2012
3Carcinoma (Carcinomatosis)
05/2004 - 05/2003
2Dermatitis
10/2022 - 09/2016
2Goiter
01/2022 - 11/2004
2Fistula
01/2022 - 07/2021
2Carcinogenesis
10/2021 - 02/2021
2Weight Loss (Weight Reduction)
01/2021 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2020 - 09/2003
2Headache (Headaches)
09/2016 - 01/2012
2Overweight
06/2014 - 07/2005
2Nodular Goiter
03/2013 - 11/2004
2Autoimmune Diseases (Autoimmune Disease)
07/2008 - 09/2003
2Congenital Hypothyroidism (Cretinism)
10/2003 - 09/2003
1Hypoparathyroidism
11/2022
1Malnutrition (Nutritional Deficiencies)
03/2022
1Cachexia
03/2022
1Hyperthyroidism
09/2021
1Body Weight (Weight, Body)
07/2021
1Drug-Related Side Effects and Adverse Reactions
07/2021

Drug/Important Bio-Agent (IBA)

18Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2022 - 01/2004
15lenvatinibIBA
01/2022 - 02/2015
11Tyrosine Kinase InhibitorsIBA
01/2022 - 10/2013
10IodineIBA
10/2022 - 04/2005
9AntibodiesIBA
09/2021 - 02/2003
9ThyroglobulinFDA Link
08/2020 - 01/2004
8Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2013
8vandetanib (ZD6474)IBA
01/2021 - 01/2012
7Messenger RNA (mRNA)IBA
10/2021 - 02/2003
6cabozantinibIBA
01/2022 - 08/2013
6prolinedithiocarbamate (PDTC)IBA
03/2021 - 04/2016
6Biological ProductsIBA
02/2021 - 11/2004
5Pharmaceutical PreparationsIBA
10/2022 - 08/2013
5Proteins (Proteins, Gene)FDA Link
07/2022 - 08/2003
5Capsules (Microcapsules)IBA
01/2022 - 11/2007
5Thyrotropin AlfaFDA LinkGeneric
01/2020 - 09/2002
4RNA (Ribonucleic Acid)IBA
10/2017 - 05/2003
4sodium-iodide symporter (sodium iodide symporter)IBA
06/2008 - 09/2003
3Thyroid HormonesIBA
01/2022 - 09/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2006
3Protein Isoforms (Isoforms)IBA
10/2021 - 09/2008
3Galectin 3 (LGALS3)IBA
01/2021 - 08/2003
3Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2020 - 09/2002
3anti-thyroglobulinIBA
01/2018 - 04/2012
3Sorafenib (BAY 43-9006)FDA Link
01/2017 - 07/2014
3AntigensIBA
09/2015 - 02/2003
3Carcinoembryonic AntigenIBA
09/2015 - 04/2012
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2015 - 08/2009
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2015 - 08/2009
3Thyroxine (Levothyroxine)FDA LinkGeneric
01/2005 - 09/2002
2Phosphotransferases (Kinase)IBA
01/2022 - 09/2012
2AutoantibodiesIBA
01/2020 - 07/2008
2MicroRNAs (MicroRNA)IBA
03/2019 - 01/2019
2Iodine-131IBA
01/2019 - 02/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 10/2008
2Angiopoietin-2IBA
01/2016 - 08/2015
2CarbohydratesIBA
09/2015 - 09/2013
2Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2015 - 02/2015
2Codon (Codons)IBA
06/2015 - 12/2011
2fosbretabulin (combretastatin A4)IBA
02/2014 - 12/2012
2Tumor Biomarkers (Tumor Markers)IBA
10/2013 - 09/2013
2NucleotidesIBA
03/2011 - 05/2004
1AZD 6244IBA
10/2022
1Monoclonal AntibodiesIBA
07/2022
1TabletsIBA
01/2022
1selpercatinibIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1EnzymesIBA
01/2022
1Tyrosine (L-Tyrosine)FDA Link
01/2022
1Immune Checkpoint InhibitorsIBA
09/2021
1Apoptosis Regulatory ProteinsIBA
09/2021
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
09/2021

Therapy/Procedure

26Therapeutics
03/2022 - 09/2002
15Thyroidectomy
01/2022 - 12/2002
2Lymph Node Excision (Lymph Node Dissection)
01/2022 - 08/2020
2Immunotherapy
09/2021 - 02/2003
2Radiotherapy
07/2021 - 04/2005
2Drug Tapering
07/2021 - 10/2013
2Drug Therapy (Chemotherapy)
04/2005 - 09/2002
1Operative Time
11/2022
1Length of Stay
11/2022
1Conservative Treatment
01/2022
1Operative Surgical Procedures
01/2022
1Precision Medicine
01/2022